Siguang Li, Lingsang Lin, Jie Zhao, Zehua Yang, Yi Zhong, Linhui Huang, Jie Chen, Lei Zhang, Yipeng Ding, Tian Xie
{"title":"IL5RA变体对慢性阻塞性肺疾病影响的研究。","authors":"Siguang Li, Lingsang Lin, Jie Zhao, Zehua Yang, Yi Zhong, Linhui Huang, Jie Chen, Lei Zhang, Yipeng Ding, Tian Xie","doi":"10.1080/15412555.2023.2270729","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is a complex disease, and its pathogenesis is influenced by genetic factors. This study aimed to evaluate the role of <i>IL5RA</i> genetic variation in the risk of COPD. In this study, 498 patients with COPD and 498 normal controls were recruited. Subsequently, five SNPs (rs3804795, rs2290610, rs13097407, rs334782, and rs3856850) in the <i>IL5RA</i> gene were genotyped. Logistic analysis examined the association of five single nucleotide polymorphisms (SNPs) in <i>IL5RA</i> with the risk of COPD under various genetic models. Furthermore, the association between <i>IL5RA</i> and susceptibility to COPD was comprehensively analyzed with stratification based on age, sex, smoking, and alcohol consumption. Our study showed that <i>IL5RA</i> rs13097407 reduced susceptibility to COPD (OR = 0.43, <i>p</i> < 0.001, <i>p</i> (FDR)< 0.001). On the other hand, rs3856850 was associated with an increased risk of COPD (OR = 1.71, <i>p</i> = 0.002, <i>p</i> (FDR) = 0.002). Interestingly, the effect of <i>IL5RA</i> SNPs on susceptibility to COPD was found to be influenced by factors such as sex and smoking. <i>IL5RA</i> gene variants were significantly associated with susceptibility to COPD.</p>","PeriodicalId":10704,"journal":{"name":"COPD: Journal of Chronic Obstructive Pulmonary Disease","volume":"20 1","pages":"338-347"},"PeriodicalIF":2.2000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Study of the Influence of <i>IL5RA</i> Variants on Chronic Obstructive Pulmonary Disease.\",\"authors\":\"Siguang Li, Lingsang Lin, Jie Zhao, Zehua Yang, Yi Zhong, Linhui Huang, Jie Chen, Lei Zhang, Yipeng Ding, Tian Xie\",\"doi\":\"10.1080/15412555.2023.2270729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Chronic obstructive pulmonary disease (COPD) is a complex disease, and its pathogenesis is influenced by genetic factors. This study aimed to evaluate the role of <i>IL5RA</i> genetic variation in the risk of COPD. In this study, 498 patients with COPD and 498 normal controls were recruited. Subsequently, five SNPs (rs3804795, rs2290610, rs13097407, rs334782, and rs3856850) in the <i>IL5RA</i> gene were genotyped. Logistic analysis examined the association of five single nucleotide polymorphisms (SNPs) in <i>IL5RA</i> with the risk of COPD under various genetic models. Furthermore, the association between <i>IL5RA</i> and susceptibility to COPD was comprehensively analyzed with stratification based on age, sex, smoking, and alcohol consumption. Our study showed that <i>IL5RA</i> rs13097407 reduced susceptibility to COPD (OR = 0.43, <i>p</i> < 0.001, <i>p</i> (FDR)< 0.001). On the other hand, rs3856850 was associated with an increased risk of COPD (OR = 1.71, <i>p</i> = 0.002, <i>p</i> (FDR) = 0.002). Interestingly, the effect of <i>IL5RA</i> SNPs on susceptibility to COPD was found to be influenced by factors such as sex and smoking. <i>IL5RA</i> gene variants were significantly associated with susceptibility to COPD.</p>\",\"PeriodicalId\":10704,\"journal\":{\"name\":\"COPD: Journal of Chronic Obstructive Pulmonary Disease\",\"volume\":\"20 1\",\"pages\":\"338-347\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"COPD: Journal of Chronic Obstructive Pulmonary Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/15412555.2023.2270729\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/31 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"COPD: Journal of Chronic Obstructive Pulmonary Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15412555.2023.2270729","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
The Study of the Influence of IL5RA Variants on Chronic Obstructive Pulmonary Disease.
Chronic obstructive pulmonary disease (COPD) is a complex disease, and its pathogenesis is influenced by genetic factors. This study aimed to evaluate the role of IL5RA genetic variation in the risk of COPD. In this study, 498 patients with COPD and 498 normal controls were recruited. Subsequently, five SNPs (rs3804795, rs2290610, rs13097407, rs334782, and rs3856850) in the IL5RA gene were genotyped. Logistic analysis examined the association of five single nucleotide polymorphisms (SNPs) in IL5RA with the risk of COPD under various genetic models. Furthermore, the association between IL5RA and susceptibility to COPD was comprehensively analyzed with stratification based on age, sex, smoking, and alcohol consumption. Our study showed that IL5RA rs13097407 reduced susceptibility to COPD (OR = 0.43, p < 0.001, p (FDR)< 0.001). On the other hand, rs3856850 was associated with an increased risk of COPD (OR = 1.71, p = 0.002, p (FDR) = 0.002). Interestingly, the effect of IL5RA SNPs on susceptibility to COPD was found to be influenced by factors such as sex and smoking. IL5RA gene variants were significantly associated with susceptibility to COPD.
期刊介绍:
From pathophysiology and cell biology to pharmacology and psychosocial impact, COPD: Journal Of Chronic Obstructive Pulmonary Disease publishes a wide range of original research, reviews, case studies, and conference proceedings to promote advances in the pathophysiology, diagnosis, management, and control of lung and airway disease and inflammation - providing a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care.